Abstract:In the current study, we synthesized a series of new compounds targeting tubulin and tested their anti proliferative activities. Among these new synthetic compounds, 5-(furan-2-yl)-4-(3,4,5-trimethoxyphenyl)-3H-1,2-dithio1-3- one oxime (6f) exhibited significant anti-proliferative activity against different human cancer cell lines including human gastric adenocarcinoma SGC-7901, human non-small cell lung cancer A549, and human fibrosarcoma HT-1080. As a result, 6f was selected to further test the sensitivity to different cancer cell lines including human cervical cancer cell line HeLa, human breast cancer cell line MCF-7, non-small cell lung cancer cell line A549, human liver carcinoma cell line HepG-2, human oral squamous cell carcinoma cell lines KB, SGC-7901 and HT-1080. Among these cell lines, HT-1080 and HeLa are the most sensitive. Therefore, HT-1080 was selected to further explore the properties of anti-proliferative activity and the underlying mechanisms. Our data proved that 6f exhibited strong anti proliferative effects against HT-1080 cells in a time- and dose-dependent manner. We showed that the growth inhibitory effect of 6f in HT-1080 cells was related with microtubule depolymerisation. Molecular docking studies revealed that 6f interacted and bound efficiently with the colchicine-binding site of tubulin. In addition, 6f treatment induced G2/M cell cycle arrest dose-dependently and subsequently induced cell apoptosis. Western blot study indicated that upregulation of cyclin B1 and p-cdc2 was related with G2/M arrest. 6f-induced cell apoptosis was associated with both mitochondrial and death receptor pathway. In conclusion, our data showed that 6f, among the newly synthetic compounds, exhibited highest anti-proliferative activity by disrupting the microtubule polymerisation, causing G2/M arrest and subsequently inducing cell apoptosis in HT-1080 cells. Hence, 6f is a promising microtubule depolymerising agent for the treatment of various cancers especially human fibrosarcoma.

Sophoridinol derivative 05D induces tumor cells apoptosis by topoisomerase1-mediated DNA breakage

Design, Synthesis, Biological Evaluation and Structure-Activity Relationship of Sophoridine Derivatives Bearing Pyrrole or Indole Scaffold As Potential Antitumor Agents

QSAR prediction, synthesis, anticancer evaluation, and mechanistic investigations of novel sophoridine derivatives as topoisomerase I inhibitors

A novel topoisomerase I inhibitor DIA-001 induces DNA damage mediated cell cycle arrest and apoptosis in cancer cell.

Sophoridine is a New Antitumor Medicine with New Molecular Structure

Sophoridine Exerts Tumor-Suppressive Activities Via Promoting ESRRG-mediated Β-Catenin Degradation in Gastric Cancer

Alkaloids from Oxytropis Ochrocephala and Antiproliferative Activity of Sophoridine Derivatives Against Cancer Cell Lines.

Sophoridine Derivatives Induce Apoptosis and Autophagy to Suppress the Growth of Triple‐Negative Breast Cancer through Inhibition of mTOR Signaling

Sophoridine Antiproliferative Effects in Human Thyroid Carcinoma Cells Mediated by Regulating PI3K/AKT/m-TOR Signalling Pathway

Exploring Derivatives of Quinolizidine Alkaloid Sophoridine in the Design and Biological Mechanistic Evaluation of Histone Deacetylase Inhibitors for Triple‐Negative Breast Cancer

Sophoridine Inhibits Lung Cancer Cell Growth and Enhances Cisplatin Sensitivity Through Activation of the P53 and Hippo Signaling Pathways.

Design, Synthesis and Evaluation of Novel Sophoridinic Imine Derivatives Containing Conjugated Planar Structure As Potent Anticancer Agents.

Sophorolipid produced from the new yeast strain Wickerhamiella domercqiae induces apoptosis in H7402 human liver cancer cells

Sophoridine Suppresses Cell Growth in Human Medulloblastoma Through FoxM1, NF-κB and AP-1.

Development of Oxoisoaporphine Derivatives with Topoisomerase I Inhibition and Reversal of Multidrug Resistance in Breast Cancer MCF-7/ADR Cells.

CS1 is a Novel Topoisomerase IIα Inhibitor with Favorable Drug Resistance Profiles.

Synthesis and Biological Evaluation of Xanthone Derivatives As Anti-Cancer Agents Targeting Topoisomerase II and DNA

Novel Sophoridine Derivatives Bearing Phosphoramide Mustard Moiety Exhibit Potent Antitumor Activities In Vitro and In Vivo

Sophoridine Inhibits Human Colorectal Cancer Progression Via Targeting MAPKAPK2

5-(Furan-2-yl)-4-(3,4,5-trimethoxyphenyl)-3h-1,2-dithiol-3-one Oxime (6f), a New Synthetic Compound, Causes Human FIbrosarcoma HT-1080 Cell Apoptosis by Disrupting Tubulin Polymerisation and Inducing G2/M Arrest.